Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers

Archives of Gynecology and Obstetrics

Volumn 289, Issue 3, 2014, Pages 663-670

  Bosse, Kristin ^a   Graeser, Monika ^a   Goßmann, Axel ^b   Hackenbroch, Matthias ^c   Schmutzler, Rita K ^a   Rhiem, Kerstin ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b Klinik Merheim   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

BRCA1 2 mutation carriers; Breast cancer; Ultrasound

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORPHOLOGY; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 84896730024     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3022-6     Document Type: Article

References (29)

1. Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130
2. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 1997; 349: 1505-10
3. Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689
4. Tilanus-Linthorst MM, Kriege M, Boetes C et al (2005) Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer 41:1610-1617
5. Da Silva L, Lakhani SR (2010) Pathology of hereditary breast cancer. Mod Pathol 23:S46-S51
6. Rhiem K, Flucke U, Schmutzler RK (2006) BRCA1-associated breast carcinomas frequently present with benign sonographic features. Am J Roentgenol 186:E11-E12 author reply E12-3
7. Brekelmans CT, Seynaeve C, Bartels CC et al (2001) Rotterdam Committee for Medical and Genetic Counseling: effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924-930
8. Vasen HFA, Tesfay E, Boonstra H et al (2005) Early detection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer 41:549-554
9. Komenaka IK, Ditkoff BA, Joseph KA et al (2004) The development of interval breast malignancies in patients with BRCA mutations. Cancer 100:2079-2083
10. Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325
11. Tilanus-Linthorst MM, Obdeijn IM, Hop WC et al (2007) BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Can Res 13(24):7357-7362
12. Gierach GL, Loud JT, Chow CK, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Vachon C, Gail MH, Greene MH (2010) Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat 123(1):245-255
13. Lehman C, Lee C, Loving V, Portillo M, Peacock S, DeMartini W (2012) Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women 30-39 years of age. AJR 199:1169-1177
14. Meindl A (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97:472-480
15. Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, Peock S, Fricker JP, Nogues C, Van't Veer L, Van Leeuwen FE, Goldgar DE (2006) Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol 24(21):3361-3366
16. American College of Radiology and (ACR) reporting system (1993) Breast Imaging and Reporting and Data System (BI-RADS), 2nd edn. American College of Radiology, Reston, pp 15-18
17. Mesurolle B, Kadoch L, El-Khoury M, Lisbona A, Dendukuri N, Foulkes WD (2007) Sonographic features of breast carcinoma presenting as masses in BRCA gene mutation carriers. J Ultrasound Med 26(6):817-824
18. Berg WA (2009) Tailored supplemental screening for breast cancer: what now and what next? AJR 193:1188 author reply
19. Hwang ES, McLennan JL, Moore DH et al (2007) Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol 25(6):642-647
20. Warner W, Causer Petrina A, Wong John W-N et al (2011) Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study. Breast J 17(1):9-17
21. Kuhl CK, Schmutzler RK, Leutner CC et al (2000) Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215:267-279
22. Libermann L (2004) Breast cancer sreening with MRI - What are the data for the patients at high risk? N Eng J Med 351:497-500 Editorial
23. Kriege M, Brekelmans CT, Boetes C et al (2004) Magnetic Resonance Imaging Screening Study Group: efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437
24. Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778
25. Passaperuma K, Warner E, Causer PA, Hill KA, Messner S, Wong JW, Jong RA, Wright FC, Yaffe MJ, Ramsay EA, Balasingham S, Verity L, Eisen A, Curpen B, Shumak R, Plewes DB, Narod SA (2012) Long-term results of screening with magnetic resonance imaging in women with BRCA mutations. Br J Cancer 107:24-30
26. Heijnsdijk EA, Warner E, Gilbert FJ, Tilanus-Linthorst MM, Evans G, Causer PA, Eeles RA, Kaas R, Draisma G, Ramsay EA, Warren RM, Hill KA, Hoogerbrugge N, Wasser MN, Bergers E, Oosterwijk JC, Hooning MJ, Rutgers EJ, Klijn JG, Plewes DB, Leach MO, de Koning HJ (2012) Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev 21(9):1458-1468
27. Saslow D, Boetes C, Burke W et al (2007) American Cancer Society Breast Cancer Advisory Group: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75-89 Erratum in: CA Cancer J Clin 2007, 57:185
28. Dent R, Warner E (2007) Screening for hereditary breast cancer. Semin Oncol 34:392-400
29. NICE Guidelines: CG41: Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care